GENPREX (GNPX) vs Valion Bio, Inc. (VBIO)

GENPREX and Valion Bio, Inc. are both Biotechnology companies. GENPREX and Valion Bio, Inc. are of similar size ($3.0M and $2.8M). Valion Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. Across the 11 metrics below, GENPREX leads on 9 and Valion Bio, Inc. on 2.

Valuation

Metric GNPX VBIO Biotechnology median
P/E 0.05 n/m 7.88
P/S n/m 0.84 11.47
P/B 0.11 0.10 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.86 n/m 0.74
EV/Sales n/m 11.80 10.73
Earnings yield 2,033.43% (6,048.69%) (28.84%)
Free cash flow yield (950.28%) (3,751.73%) (23.03%)

Profitability

Metric GNPX VBIO Biotechnology median
Gross margin 0.00% (58.09%) 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (203.86%) (489.30%) (57.72%)
Return on assets (157.40%) (104.96%) (49.22%)
Return on invested capital 0.00% (61.01%) 0.00%

Growth

Metric GNPX VBIO Biotechnology median
Revenue growth (TTM) — (49.63%) 5.64%
EPS growth (last fiscal year) 93.48% 60.16% —
Revenue growth, 5-year CAGR — 13.18% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNPX VBIO Biotechnology median
Debt to equity 0.00 0.62 0.00
Current ratio 6.76 1.11 4.73
Net debt to EBITDA 0.50 0.79 0.96

Dividend

Metric GNPX VBIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GNPX VBIO Biotechnology median
Market cap 2.80m 2.97m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack